Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4297950

EFBEMALENOGRASTIM ALFA
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
No structure available
ChEMBL ↗

Basic Information

ChEMBL ID CHEMBL4297950
Name EFBEMALENOGRASTIM ALFA
Phase Approved
Structure Type NONE
Therapeutic ✓ Yes

Known Names

Benegrastim Efbemalenograstim alfa Efbemalenograstim alfa-vuxw F-627 F627 Rh g-csf fc fusion protein f-627 Ryzneuta
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
7
Known Names
4
Indications
1
Mechanisms

Drug Information

Molecule Type Protein
First Approval 2023
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Parenteral
USAN Stem ef-; -stim

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Granulocyte colony stimulating factor receptor agonist AGONIST Granulocyte colony-stimulating factor receptor ✓ ✓

Indications

Chemotherapy-Induced Febrile Neutropenia Neoplasms Neutropenia Breast Neoplasms

ATC Classification

L03AA18
efbemalenograstim alfa
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: IMMUNOSTIMULANTS

Data from ChEMBL 36 via Core Engine